Corrigendum

Corrigendum Corrigendum (811) Total Article Views Authors: Boyer TD, Medicis JJ, Pappas SC, Potenziano J, Jamil K Published Date August 2012 Volume 2012:4 Pages 59 - 60 DOI: http://dx.doi.org/10.2147/OAJCT.S36089 Received: 18 July 2012 Accepted: Published: 13 August 2012 Boyer TD, Medicis JJ, Pappas SC, Potenziano J, Jamil K. A randomized, placebo-controlled, double-blind study to confirm the reversal of hepatorenal syndrome type 1 with terlipressin: the REVERSE trial design. Open Access Journal of Clinical Trials. 2012;4:39–49. Dr Jamil’s first name was incorrectly spelt as Khuramm Jamil in the author list. The correct spelling is Khurram Jamil. Read the original article Post to: Cannotea Citeulike Del.icio.us Facebook LinkedIn Twitter Other articles by Dr Khuramm Jamil A randomized, placebo-controlled, double-blind study to confirm the reversal of hepatorenal syndrome type 1 with terlipressin: the REVERSE trial design Readers of this article also read: Local anesthetic failure associated with inflammation: verification of the acidosis mechanism and the hypothetic participation of inflammatory peroxynitrite Narcissistic rage: The Achilles’ heel of the patient with chronic physical illness The cognitive basis of diglossia in Arabic: Evidence from a repetition priming study within and between languages Potential renovascular hypertension, space missions, and the role of magnesium Prolonged rupture of membranes in term infants: should all babies be screened? Morgellons disease: Analysis of a population with clinically confirmed microscopic subcutaneous fibers of unknown etiology Subset-directed antiviral treatment of 142 herpesvirus patients with chronic fatigue syndrome Amino acid management of Parkinson’s disease: a case study Intercellular cancer collisions generate an ejected crystal comet tail effect with fractal interface embryoid body reassembly transformation Fungus-mediated biological synthesis of gold nanoparticles: potential in detection of liver cancer